Practice Pattern of Gastroenterologists for the Management of GERD Under the Minimal Influence of the Insurance Reimbursement Guideline: A Multicenter Prospective Observational Study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q3
- 저널
- JOURNAL OF KOREAN MEDICAL SCIENCE26(12) · pp.1613 · 2011
- 피인용
- Web of Science 1KCI 0
- JCR IF
- JCR 2010 0.834
- ISSN
- 1011-8934
저자
- 이광재제1저자아주대학교
- 김진일가톨릭대학교
- 박주상분당제생병원
- 문병식부천세종병원
- 김상균서울대학교병원
- 천재희연세대학교
- 정훈용울산대학교
- 최창환중앙대학교
- 전성우경북대학교
- 송근암부산대학교
- 최명규분당제생병원
- 전훈재교신저자고려대학교
초록
The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guideline on the use of proton pump inhibitors (PPIs), rabeprazole was used for the PPI treatment. A total of 861 patients (72%) underwent endoscopy before the start of treatment. PPIs were most commonly prescribed (87%). At the start of treatment, rabeprazole 20 mg daily was prescribed to 94% of the patients who received PPI treatment and 10 mg daily to the remaining 6%. At the third visits, rabeprazole 20 mg daily was prescribed to 70% of those who were followed and 10 mg daily for the remaining 30%. Continuous PPI treatment during the 16-week period was performed in 63% of the study patients. In conclusion, a full-dose PPI is preferred for the initial and maintenance treatment of GERD under the minimal influence of the insurance reimbursement guideline, which may reflect a high proportion of GERD patients requiring a long-term treatment of a full-dose PPI.
키워드
Gastroesophageal Reflux DiseaseKoreaProton Pump InhibitorsGASTROESOPHAGEAL-REFLUX DISEASEPROTON-PUMP INHIBITORSEROSIVE ESOPHAGITISPREVALENCEPOPULATIONKOREAEPIDEMIOLOGYLANSOPRAZOLEPANTOPRAZOLERANITIDINE
식별자
- WoS UID
- 000298034000012
- KCI
- ART001608098



로그인
연구물 목록으로